EN
Back to the archive

The archive · Product Ideas · Product decision · 2021

Nurofen releases 'Tune Out Pain', pharmacologically engineered music that eases minor pain

Nurofen launched free music engineered pharmacologically to activate the brain's own opioids — clinically shown to ease minor pain in 77% of cases.

Nurofen

The ideaInstead of a faster pill, release music composed pharmacologically to activate the brain's endogenous opioids and shift focus from pain to pleasure.incremental

What it had to solve

Pain affects 80% of people daily, and even minor pain sends them reaching for pills. Nurofen, a leading pain-relief brand, wanted to reduce the public's dependence on medication — so it set out to transform the category with a new kind of product rather than another tablet.

How it works

Pain affects 80% of people daily, and even minor pains push them toward pills. Nurofen, a leading pain-relief brand, took the opposite route from a bigger marketing push: it decided to reduce the public's dependence on medication by giving the category a new kind of product.

Working with University College Dublin and a musician, Nurofen composed 'Tune Out Pain', described as the first piece of music written pharmacologically — engineered to target the brain, activate its endogenous opioids and force it to focus on pleasure instead of pain.

The track is clinically shown to help in 77% of cases, free, safe for all and usable anywhere, which turns it into an alternative people can actually choose at the moment of minor pain. The project entered D&AD's awards archive under Impact as a documented reinvention of what a pain-relief brand can offer.

Why it lands

  • The product, not the message, was the idea: instead of another ad for pills, Nurofen built a free substitute that treats the same minor pain.
  • Composing pharmacologically gave the music a mechanism — endogenous opioid activation — that could be clinically tested, so the brand claimed physiology rather than mood.
  • Free and usable anywhere removed the cost and access barriers that come with buying a medicine.
  • A 77% clinical result let the idea be judged on evidence, which is what made it a category move rather than a music-marketing stunt.

What it did

Clinically shown to help manage smaller pains in 77% of cases, and released free so anyone in pain could use it anywhere. The work entered D&AD's awards archive under Impact as a new kind of product for the pain-relief category — an analgesic brand shipping sound instead of pills.

Case pageTune Out Pain on the D&AD archive

What you can take

When the category's own habit — reaching for pills — is the harm, don't sell louder: engineer a free alternative that works through the body's own pain system, and prove it clinically.

Since then

The work entered D&AD's awards archive under Impact, where it is filed as a new kind of product for a category built on pills. No download or sales figures are archived with it; what survives is the composition itself and its measured claim — the first music written pharmacologically, clinically shown to help in 77% of cases. The move reframed Nurofen's competitive question from 'which pill is faster' to 'does the pain need a pill at all', and left a template: a pharma brand answering over-medication with a free alternative that works through the body's own chemistry.

Sources

spotted an error? The archive wants to know.

Your turn

You just read one. Describe the brief you are staring at, and see who has been given the same problem.

Free account · 3 free questions · no card

Related cases